FIELD: medicine, ophthalmology.
SUBSTANCE: method involves intravenous administration of metypred in every other day being in the 1-st and 3-d days the dose is by 500.0 mg, in 5-th and 7-th day - by 250.0 mg, and in 9-th and 10-th day - by 125 mg. In onset of metypred administration dexamethasone in the dose 1.0 ml is administrated by retrobulbar route every day for 10 days. Also, method involves pterygopalatine blockade including dexamethasone, ketorol, emoxipine, lidocaine, dalargin in doses 1.0; 1.0; 1.0; 2.0 ml and 0.001 g every day for 5 days and then 3 blockades in every other day, one blockade per a day. Method expands assortment of therapeutic approaches in treatment of acute optical neuritis in patients with cerebrospinal sclerosis.
EFFECT: improved and enhanced treatment method.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEX THERAPY METHOD FOR TREATING OPTICAL NEURITIS CASES | 2006 |
|
RU2320300C1 |
METHOD OF OPTICAL NEURITIS TREATMENT | 2009 |
|
RU2414900C1 |
METHOD OF TREATING MONOCULAR OPTIC NEURITIS ACCOMPANYING MULTIPLE SCLEROSIS | 2013 |
|
RU2523146C1 |
METHOD FOR COMPLEX TREATMENT OF INFECTIOUS ACUTE OPTICAL NEURITIS | 2016 |
|
RU2623870C1 |
METHOD OF TREATING OPTIC NERVE ATROPHY OF VASCULAR GENESIS | 2011 |
|
RU2452436C1 |
METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
METHOD FOR TREATMENT OF POSTINFLUENZAL RETROBULBAR NEURITIDES | 0 |
|
SU1738276A1 |
METHOD OF TREATING VISUAL PATHWAY DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS | 2011 |
|
RU2479328C2 |
METHOD FOR TREATING OPTIC NEURITIS AT OPTICOCHIASMIC ARACHNOIDITIS AT REMISSION STAGE | 2005 |
|
RU2284814C1 |
METHOD OF ENDOCRINE OPHTHALMOPATHY TREATMENT | 2020 |
|
RU2725861C1 |
Authors
Dates
2005-10-10—Published
2004-04-27—Filed